Sign in / Join Now
ETFs & Funds
Looks like usual suspects are silent now on
on 7/17 would be big for
which is priced too low for approval anyway.
Add a reply...
Latest StockTalks »
people get SPPI breaking news and analysis by email alert.
Get email alerts on SPPI »
Spectrum Pharmaceuticals, Inc.
Get latest price
From other sites
Commit To Purchase Spectrum Pharmaceuticals At $3, Earn 16.6% Annualized Using Options
at TheStreet (Dec 23, 2016)
Spectrum Pharmaceuticals Highlights Promising Preclinical Data Evaluating Poziotinib In Lung Cancer At The 17th IASLC World Conference On Lung Cancer
at TheStreet (Dec 8, 2016)
Spectrum Pharmaceuticals Highlights Survival Advantage In A Case Match Control Analysis Of The PROPEL Study With FOLOTYN® (pralatrexate Injection) at The 58th Annual Meeting Of The American Society Of Hematology (ASH)
at TheStreet (Dec 6, 2016)
Spectrum Pharmaceuticals Highlights Five Abstracts On ROLONTIS™ (eflapegrastim) And Poziotinib At The San Antonio Breast Cancer Symposium (SABCS) In San Antonio, Texas, December 6-10, 2016
at TheStreet (Dec 5, 2016)
Spectrum Pharmaceuticals Highlights Four Abstracts At The 58th Annual Meeting Of The American Society Of Hematology (ASH) In San Diego, California, December 3-6, 2016
at TheStreet (Dec 2, 2016)